Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.328 |
---|---|
High | 0.328 |
Low | 0.301 |
Bid | 0.3105 |
Offer | 0.356 |
Previous close | 0.32 |
Average volume | 0.00 |
---|---|
Shares outstanding | 1.34m |
Free float | 1.22m |
P/E (TTM) | -- |
Market cap | 428.94k EUR |
EPS (TTM) | -32.56 EUR |
Data delayed at least 15 minutes, as of Oct 09 2024.
More ▼
Announcements
- Oxurion Share Consolidation
- Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
- Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024
- Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production
- Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024
- Oxurion Announces Extraordinary General Shareholders’ Meeting
- Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024
- Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD
More ▼